January 22, 2022

News

News Network

Statement Of AAG Makan Delrahim Thanking Participants In Workshop On Competition In The Licensing Of Public Performance Rights In The Music Industry

10 min read
<div>On Wednesday July 29, the Justice Department’s Antitrust Division concluded its two-day virtual workshop on competition in the licensing of public performance rights in the music industry.</div>

On Wednesday July 29, the Justice Department’s Antitrust Division concluded its two-day virtual workshop on competition in the licensing of public performance rights in the music industry.

“I want to thank our panelists and keynote songwriters for participating in this important workshop on the ASCAP and BMI consent decrees,” said Assistant Attorney General Makan Delrahim.  “Watching and listening to them over the last two days, I was struck by how many talented people with very different backgrounds the workshop brought together.  Songwriters, lawyers, economists, and CEOs obviously have very different skill sets.  Yet all the participants were exceptional, talented, and insightful.”   

“This diverse representation underscores the free market principles that the Antitrust Division defends.  The ability to succeed as an entrepreneur, as an innovator, as a songwriter, or as another creative professional is the economic freedom promised by competitive markets.  That freedom is what the attorneys and economists at the Antitrust Division devote themselves to upholding.” 

“This week’s proceedings underscored that liberty in free markets is important to our country, and it’s important to the music industry.  As the Antitrust Division considers the appropriate path forward, we will strive to find the one that best supports this critical industry.”

The participants in the event included:

  • LeAnn Rimes
  • Pharrell Williams
  • Jon Bon Jovi
  • David Israelite, President and CEO, National Music Publishers’ Association (NMPA)
  • Michelle Lewis, Executive Director, Songwriters of North America (SONA)
  • Elizabeth Matthews, CEO, American Society of Composers, Authors, and Publishers (ASCAP)
  • Michael O’Neill, President and CEO, Broadcast Music Inc. (BMI)
  • The Honorable Gordon Smith, President and CEO, National Association of Broadcasters (NAB)
  • Jackie Brenneman, General Counsel, National Association of Theatre Owners
  • Ted Cohen, Managing Partner, TAG Strategic
  • David Kokakis, Chief Counsel, Universal Music Publishing Group
  • Janet McHugh, Executive Director, TV Music License Committee
  • Mike Steinberg, Executive Vice President of Creative and Licensing, BMI
  • Danielle Aguirre, Executive Vice President and General Counsel, NMPA
  • Jordan Bromley, Board Member, Music Artists Coalition
  • Bart Herbison, Executive Director, Nashville Songwriters Association International
  • Clara Kim, Executive Vice President and General Counsel, Business and Legal Affairs, ASCAP
  • Jack Kugell, Board Member, SONA
  • John Bodnovich, Executive Director, American Beverage Licensees
  • Peter Brodsky, General Counsel and Executive Vice President, Business Affairs, Sony/ATV Music Publishing
  • Rick Kaplan, General Counsel and Executive Vice President, Legal and Regulatory Affairs, NAB
  • Stuart Rosen, Senior Vice President and General Counsel, BMI
  • Tres Williams, Executive Vice President, Business Affairs, iHeartMedia, Inc.
  • Adam B. Jaffe, Brandeis University
  • Kevin M. Murphy, University of Chicago

A transcript and video of the proceedings will be available in the coming days on the workshop page, located at https://www.justice.gov/atr/events/public-workshop-competition-licensing-music-public-performance-rights.  Assistant Attorney General Makan Delrahim’s opening statement is available at here.

News Network

  • Designation of al-Qa’ida Network in Brazil
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Corrections officer indicted for providing meth and sex to an inmate
    In Justice News
    A 38-year-old Beeville [Read More…]
  • Public Designation of Oligarch and Former Ukrainian Public Official Ihor Kolomoyskyy Due to Involvement in Significant Corruption
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • MS-13 Member Pleads Guilty to Racketeering Conspiracy Involving Murder and Attempted Murder
    In Crime News
    A Maryland man pleaded guilty today to conspiracy to participate in a racketeering enterprise by murdering a suspected rival gang member and attempting to murder two other victims, in connection with his MS-13 gang activities. 
    [Read More…]
  • Safe Haven for Hong Kongers
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Election of Fiame Naomi Mata’afa as Prime Minister of Samoa
    In Crime Control and Security News
    Ned Price, Department [Read More…]
  • Situation in Tunisia
    In Crime Control and Security News
    Ned Price, Department [Read More…]
  • Costa Rica Travel Advisory
    In Travel
    Do not travel to Costa [Read More…]
  • Statement of Attorney General Merrick B. Garland on the Life of Judge Robert Katzmann
    In Crime News
    U.S. Attorney General Merrick B. Garland made the following statement on the passing of Judge Robert Katzmann:
    [Read More…]
  • Mississippi Pharmacist Pleads Guilty to More than $180-Million Health Care Fraud Scheme
    In Crime News
    A Mississippi pharmacist pleaded guilty today for his role in a multimillion-dollar scheme to defraud TRICARE and private insurance companies by paying kickbacks to distributors for the referral of medically unnecessary compounded prescription medications that were ultimately dispensed by his pharmacies. The conduct allegedly resulted in more than $180 million in fraudulent billings, including more than $50 million paid by federal healthcare programs. 
    [Read More…]
  • Earth Day 2021
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Veterans Health Care: Addressing High Risk Concerns for Oversight and Accountability Are Key to Ensuring Quality of Care and Patient Safety
    In U.S GAO News
    What GAO Found GAO's work has identified a range of concerns with the Department of Veterans Affairs' (VA) oversight and accountability of its health care system, including those related to quality of care and patient safety. Since GAO added VA health care to its High-Risk List in 2015, GAO has made 131 recommendations related to VA's oversight and accountability, almost half of all GAO's recommendations for VA health care. Recent examples of quality of care and patient safety recommendations include the following: VA has faced challenges in ensuring that its providers deliver safe and effective care to veterans. In February 2021, GAO identified 227providers that had been removed from VA employment but were potentially providing care in a community care network. GAO recommended that VA take actions to assess and address the situation.VA implemented this recommendation by reviewing and excluding 155providers from participating in VA's community care networks. In recent years, there have been reports of veterans dying by suicide on VA campuses—in locations such as inpatient settings, parking lots, and on the grounds of VA cemeteries. In September 2020, GAO found that VA lacks accurate information on the number of suicides and comprehensive analyses of the underlying causes. While VA agreed with two of GAO's recommendations to address these issues, VA still needs to provide documentation of key actions taken by the committee it established to improve its understanding of on-campus suicides. In June 2019, GAO found that VA's oversight of its regional health care networks was limited. GAO recommended that VA develop a process for assessing the overall performance of its networks to be able to better determine if a network's performance is positive, if it is functioning poorly, or if it requires remediation. While VA concurred with GAO's recommendation, VA still needs to provide documentation of the process developed to assess the overall performance of these networks in managing medical centers. Since the last high-risk update in March 2021, VA has taken steps to address some of the oversight and accountability concerns identified by GAO. In May 2021, VA published a revised high-risk action plan for addressing VA health care concerns. However, VA is still in the beginning stages of developing its plan to address root causes such as a fragmented oversight and accountability infrastructure and will need clearly defined metrics to ensure it is effective. Fully addressing oversight and accountability concerns also requires sustained leadership attention as well as leadership stability. However, the Under Secretary for Health position responsible for managing VA health care has not had permanent leadership since January 2017. While VA takes steps to address its needed transformation, it should continue to implement recommendations GAO has made in the oversight and accountability area, given the number of these similar types of recommendations and the need to ensure quality of care and patient safety. Why GAO Did This Study VA operates one of the nation's largest health care systems. GAO's work, along with that of VA's Office of Inspector General and others, has cited longstanding issues with VA's oversight of its health care system. In 2015, GAO added VA health care to its High-Risk List, in which one broad area of concern was inadequate oversight and accountability. In its latest high-risk update in March 2021, GAO noted continued concern over VA's ability to ensure the safety and protection of patients and staff, as well as to oversee its programs. This statement describes the oversight and accountability issues GAO's work has identified related to quality care and patient safety, and the status of VA's efforts to address its high-risk designation. This statement is based on GAO's body of work in this area. GAO’s Fiscal Year 2021 Rating for the Inadequate Oversight and Accountability Area For more information, contact Sharon M. Silas at (202) 512-7114 or silass@gao.gov.
    [Read More…]
  • Acting Assistant Attorney General Brian C. Rabbitt Delivers Remarks at Shinshu University 2nd White Collar Crime Workshop
    In Crime News
    Good morning. It is my pleasure to be with you today, even if only through a video screen. Thank you very much to Shinshu University and my hosts for your kind invitation to join the list of distinguished speakers, panelists, and participants in today’s important event. It is my great privilege to be here today representing the women and men of the Criminal Division of the U.S. Department of Justice, and I look forward to speaking with you about some of our important work over the past year enforcing the federal criminal laws.
    [Read More…]
  • Secretary Blinken’s Call with Kuwaiti Foreign Minister Al-Sabah
    In Crime Control and Security News
    Office of the [Read More…]
  • United States Joins Christchurch Call to Action to Eliminate Terrorist and Violent Extremist Content Online
    In Crime Control and Security News
    Ned Price, Department [Read More…]
  • Prescription Drugs: Medicare Spending on Drugs with Direct-to-Consumer Advertising
    In U.S GAO News
    What GAO Found Drug manufacturers spent $17.8 billion on direct-to-consumer advertising (DTCA) for 553 drugs from 2016 through 2018, and spending was relatively stable at about $6 billion each year. Almost half of this spending was for three therapeutic categories of drugs that treat chronic medical conditions, such as arthritis, diabetes, and depression. GAO also found that nearly all DTCA spending was on brand-name drugs, with about two-thirds concentrated on 39 drugs, about half of which entered the market from 2014 through 2017. Medicare Parts B and D and beneficiaries spent $560 billion on drugs from 2016 through 2018, $324 billion of which was spent on advertised drugs. Of the 553 advertised drugs, GAO found Medicare Parts B and D spending for 104 and 463 drugs, respectively. Among the drugs with the highest Medicare spending, some also had the highest DTCA spending. Specifically, among the top 10 drugs with the highest Medicare Parts B or D expenditures, four were also among the top 10 drugs in advertising spending in 2018: Eliquis (blood thinner), Humira (arthritis), Keytruda (cancer), and Lyrica (diabetic pain). Medicare Spending on Advertised Drugs, 2016 - 2018 GAO's review of four advertised drugs found that drug manufacturers changed their DTCA spending during key events, such as increasing spending when a drug was approved to treat additional conditions or decreasing spending following the approval of generic versions. GAO also found that DTCA may have contributed to increases in Medicare beneficiary use and spending among four selected drugs from 2010 through 2018. However, other factors likely contributed to a drug's Medicare beneficiary use and spending, making it difficult to isolate the relationship between drug advertising, use and spending. For example, GAO's review of four selected drugs showed that increases in unit prices were a factor, while stakeholders GAO interviewed cited other contributing factors such as doctors' prescribing decisions and manufacturers' drug promotions directed to doctors. Why GAO Did This Study Drug manufacturers use advertising on television and in other media to promote the use of their drugs to consumers and to encourage them to visit their doctors for more information. From 2016 through 2018, the Medicare program and beneficiaries spent $560 billion on drugs, and spending is projected to increase with the use of newer, more expensive drugs and an increase in beneficiaries. GAO was asked to examine DTCA and Medicare spending on advertised drugs. This report examines (1) drug manufacturer spending on DTCA; (2) Medicare spending on advertised drugs; and (3) changes in DTCA spending and Medicare use and spending for selected drugs. GAO analyzed DTCA spending data from Nielsen Media, and Medicare Parts B and D Drug Spending Dashboard data, from 2016 through 2018 (the most recent available data at the time of GAO's analysis). GAO also analyzed DTCA spending and Medicare data for a non-generalizable selection of four advertised drugs over a longer period—from 2010 through 2018. The four drugs were selected to reflect differences in DTCA and Medicare spending, beneficiary use, and medical conditions treated. GAO also interviewed or obtained information from officials representing 14 stakeholder groups (including research, trade, and physician organizations; and drug manufacturers of the four selected drugs) about DTCA spending and drug use and spending. The Department of Health and Human Services provided technical comments on a draft of this report, which GAO incorporated as appropriate. For more information, contact John Dicken at (202) 512-7114 or dickenj@gao.gov.
    [Read More…]
  • On the Anniversary of the Marine Barracks Terrorist Attack 
    In Crime Control and Security News
    Michael R. Pompeo, [Read More…]
  • How NASA’s Perseverance Mars Team Has Adjusted to Work in the Time of Coronavirus
    In Space
    Like much of the rest of [Read More…]
  • MS-13 Member Sentenced to 35 Years’ Imprisonment for Racketeering Conspiracy and Other Violent Crimes
    In Crime News
    A Maryland man was sentenced yesterday to 35 years in prison for conspiracy to participate in a racketeering enterprise, murder and attempted murder in aid of racketeering, and other charges in connection with his La Mara Salvatrucha, aka “MS-13” gang, activities between 2015 and 2019.
    [Read More…]
  • Deputy Attorney General Lisa O. Monaco Delivers Remarks on Operation Dark HunTor
    In Crime News
    Good morning and thank you for being here today. I am pleased to be joined this morning by the Deputy Executive Director of EUROPOL, Jean-Philippe Lecouff, as well as the Assistant Attorney General of the Criminal Division Kenneth Polite Jr., FBI Deputy Director Paul Abbate, DEA Administrator Anne Milgram, and leaders of several law enforcement partners.
    [Read More…]

Crime

Network News © 2005 Area.Control.Network™ All rights reserved.